rs17722172

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_133642.5(LARGE1):​c.2100C>T​(p.Asn700Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0598 in 1,613,914 control chromosomes in the GnomAD database, including 3,243 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 220 hom., cov: 32)
Exomes 𝑓: 0.061 ( 3023 hom. )

Consequence

LARGE1
NM_133642.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.165

Publications

8 publications found
Variant links:
Genes affected
LARGE1 (HGNC:6511): (LARGE xylosyl- and glucuronyltransferase 1) This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]
LARGE1 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy type B6
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 22-33274598-G-A is Benign according to our data. Variant chr22-33274598-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.165 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0677 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133642.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
NM_133642.5
MANE Select
c.2100C>Tp.Asn700Asn
synonymous
Exon 15 of 15NP_598397.1O95461-1
LARGE1
NM_001362949.2
c.2100C>Tp.Asn700Asn
synonymous
Exon 16 of 16NP_001349878.1O95461-1
LARGE1
NM_001362951.2
c.2100C>Tp.Asn700Asn
synonymous
Exon 15 of 15NP_001349880.1O95461-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
ENST00000397394.8
TSL:5 MANE Select
c.2100C>Tp.Asn700Asn
synonymous
Exon 15 of 15ENSP00000380549.2O95461-1
LARGE1
ENST00000354992.7
TSL:1
c.2100C>Tp.Asn700Asn
synonymous
Exon 16 of 16ENSP00000347088.2O95461-1
LARGE1
ENST00000402320.6
TSL:1
c.1944C>Tp.Asn648Asn
synonymous
Exon 14 of 14ENSP00000385223.1O95461-2

Frequencies

GnomAD3 genomes
AF:
0.0463
AC:
7044
AN:
152122
Hom.:
220
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0127
Gnomad AMI
AF:
0.0706
Gnomad AMR
AF:
0.0557
Gnomad ASJ
AF:
0.0867
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.0350
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0694
Gnomad OTH
AF:
0.0564
GnomAD2 exomes
AF:
0.0472
AC:
11842
AN:
250860
AF XY:
0.0477
show subpopulations
Gnomad AFR exome
AF:
0.0106
Gnomad AMR exome
AF:
0.0335
Gnomad ASJ exome
AF:
0.0807
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0390
Gnomad NFE exome
AF:
0.0696
Gnomad OTH exome
AF:
0.0626
GnomAD4 exome
AF:
0.0612
AC:
89503
AN:
1461674
Hom.:
3023
Cov.:
31
AF XY:
0.0603
AC XY:
43876
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.0111
AC:
370
AN:
33480
American (AMR)
AF:
0.0352
AC:
1573
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0798
AC:
2086
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0198
AC:
1712
AN:
86252
European-Finnish (FIN)
AF:
0.0443
AC:
2367
AN:
53420
Middle Eastern (MID)
AF:
0.0723
AC:
417
AN:
5768
European-Non Finnish (NFE)
AF:
0.0695
AC:
77272
AN:
1111808
Other (OTH)
AF:
0.0613
AC:
3703
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
4797
9593
14390
19186
23983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2784
5568
8352
11136
13920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0463
AC:
7042
AN:
152240
Hom.:
220
Cov.:
32
AF XY:
0.0436
AC XY:
3245
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0127
AC:
528
AN:
41564
American (AMR)
AF:
0.0555
AC:
848
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0867
AC:
301
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.0143
AC:
69
AN:
4810
European-Finnish (FIN)
AF:
0.0350
AC:
371
AN:
10606
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0693
AC:
4714
AN:
68004
Other (OTH)
AF:
0.0563
AC:
119
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
329
659
988
1318
1647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0620
Hom.:
633
Bravo
AF:
0.0456
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.0702
EpiControl
AF:
0.0711

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
2
Muscular dystrophy-dystroglycanopathy type B6 (2)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.8
DANN
Benign
0.89
PhyloP100
-0.17
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17722172; hg19: chr22-33670584; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.